Literature DB >> 25245289

Shedding of epithin/PRSS14 is induced by TGF-β and mediated by tumor necrosis factor-α converting enzyme.

Hyo Seon Lee1, Bo Mi Park1, Youngkyung Cho1, Sauryang Kim2, Chungho Kim3, Moon Gyo Kim2, Dongeun Park4.   

Abstract

Epithin/PRSS14, a type II transmembrane serine protease, plays critical roles in cancer metastasis. Previously, we have reported that epithin/PRSS14 undergoes ectodomain shedding in response to phorbol myristate acetate (PMA) stimulation. In this study, we show that transforming growth factor-β (TGF-β) induces rapid epithin/PRSS14 shedding through receptor mediated pathway in 427.1.86 thymoma cells. Tumor necrosis factor-α converting enzyme (TACE) is responsible for this shedding. Amino acid sequence encompassing the putative shedding cleavage site of epithin/PRSS14 exhibit strong homology to the cleavage site of l-selectin, a known TACE substrate. TACE inhibitor, TAPI-0 and TACE siRNA greatly reduced TGF-β-induced epithin/PRSS14 shedding. TGF-β treatment induces translocation of intracellular pool of TACE to the membrane where epithin/PRSS14 resides. These findings suggest that TGF-β induces epithin/PRSS14 shedding by mediating translocation of epithin/PRSS14 sheddase, TACE, to the membrane.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ectodomain shedding; Epithin; TGF-β; Tumor necrosis factor-α converting enzyme (TACE)

Mesh:

Substances:

Year:  2014        PMID: 25245289     DOI: 10.1016/j.bbrc.2014.09.055

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Membrane-anchored proteases in endothelial cell biology.

Authors:  Toni M Antalis; Gregory D Conway; Raymond J Peroutka; Marguerite S Buzza
Journal:  Curr Opin Hematol       Date:  2016-05       Impact factor: 3.284

2.  Impact of suppression of tumorigenicity 14 (ST14)/serine protease 14 (Prss14) expression analysis on the prognosis and management of estrogen receptor negative breast cancer.

Authors:  Sauryang Kim; Jae Woong Yang; Chungho Kim; Moon Gyo Kim
Journal:  Oncotarget       Date:  2016-06-07

3.  Matriptase shedding is closely coupled with matriptase zymogen activation and requires de novo proteolytic cleavage likely involving its own activity.

Authors:  Chun-Che Tseng; Bailing Jia; Robert Barndt; Yayun Gu; Chien-Yu Chen; I-Chu Tseng; Sheng-Fang Su; Jehng-Kang Wang; Michael D Johnson; Chen-Yong Lin
Journal:  PLoS One       Date:  2017-08-22       Impact factor: 3.240

Review 4.  SheddomeDB: the ectodomain shedding database for membrane-bound shed markers.

Authors:  Wei-Sheng Tien; Jun-Hong Chen; Kun-Pin Wu
Journal:  BMC Bioinformatics       Date:  2017-03-14       Impact factor: 3.169

5.  Intramembrane proteolysis of an extracellular serine protease, epithin/PRSS14, enables its intracellular nuclear function.

Authors:  Youngkyung Cho; Sang Bum Kim; Jiyoon Kim; An Vuong Quynh Pham; Min Ji Yoon; Jeong Hwan Park; Ki-Tae Hwang; Dongeun Park; Yongcheol Cho; Moon Gyo Kim; Chungho Kim
Journal:  BMC Biol       Date:  2020-06-03       Impact factor: 7.431

6.  Participation of the SMAD2/3 signalling pathway in the down regulation of megalin/LRP2 by transforming growth factor beta (TGF-ß1).

Authors:  Felipe Cabezas; Pamela Farfán; María-Paz Marzolo
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

7.  Environment-Sensitive Ectodomain Shedding of Epithin/PRSS14 Increases Metastatic Potential of Breast Cancer Cells by Producing CCL2.

Authors:  Jiyoung Jang; Eun Hye Cho; Youngkyung Cho; Binderya Ganzorig; Ki Yeon Kim; Moon Gyo Kim; Chungho Kim
Journal:  Mol Cells       Date:  2022-08-10       Impact factor: 4.250

8.  A JUN N-terminal kinase inhibitor induces ectodomain shedding of the cancer-associated membrane protease Prss14/epithin via protein kinase CβII.

Authors:  Joobyoung Yoon; Youngkyung Cho; Ki Yeon Kim; Min Ji Yoon; Hyo Seon Lee; Sangjun Davie Jeon; Yongcheol Cho; Chungho Kim; Moon Gyo Kim
Journal:  J Biol Chem       Date:  2020-04-02       Impact factor: 5.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.